We found that the expression of VEGF was decreased in the combined treatment group after modeling with an increased ratio of Ang-1 to Ang-2 (Figure 7), which indicated that the number of mature and stable blood vessels was increased, causing hematoma absorption and reducing vascular leakage [34, 35]. The gene discussed is VEGFA; the disease is hematoma.